Search Results - G.M. Haag

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial by R. Stelmach, S. Lorenzen, T.J. Ettrich, F.R. Longo, B. Chibaudel, R. Greil, M. Perwög, J. Larcher-Steiner, D. Jäger, F. Lordick, G. Stocker, G.M. Haag

    Published in ESMO Gastrointestinal Oncology (2026-03-01)
    Get full text
    Article


  2. 2

    TROPHIT1—a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients by B.C. Köhler, G.M. Haag, L. Le Cornet, P. Hoffmeister-Wittmann, M. Schmidt, A. Manjunath, N. Vaquero-Siguero, M. Jenzer, M. Gimmel, A. Stahler, A. Stein, M. Reichert, S. Kasper, M. Bitzer, D. Jäger, C. Springfeld, T.F. Weber, S. Fröhling, K. Steindorf, A. Trumpp, R.F. Schlenk, R. Jackstadt

    Published in ESMO Gastrointestinal Oncology (2025-03-01)
    Get full text
    Article


Search Tools: